My reading of the Declaration issued by the Dept. of Health and Human Services (portion below) is that it is ALL vaccines are covered and protected by the PREP Act, approved or not, EUA or not. Any wuflu "countermeasure" qualifies for protection from liability. Experimental or emergency use is no longer a limiting qualifier.
VI. Covered Countermeasures 42 U.S.C. 247D-6B(C)(1)(B), 42 U.S.C. 247D-6D(I)(1) AND (7) Covered Countermeasures are:
(a) Any antiviral, any drug, any biologic, any diagnostic, any other device, any respiratory protective device, or any vaccine manufactured, used, designed, developed, modified, licensed, or procured:
i. To diagnose, mitigate, prevent, treat, or cure COVID-19, or the transmission of SARS-CoV-2 or a virus mutating therefrom; or
ii. to limit the harm that COVID-19, or the transmission of SARS-CoV-2 or a virus mutating therefrom, might otherwise cause;
(b) a product manufactured, used, designed, developed, modified, licensed, or procured to diagnose, mitigate, prevent, treat, or cure a serious or life-threatening disease or condition caused by a product described in paragraph (a) above;
(c) a product or technology intended to enhance the use or effect of a product described in paragraph (a) or (b) above; or
(d) any device used in the administration of any such product, and all components and constituent materials of any such product.
Your reading matches mine. The salient point is this:
Any wuflu "countermeasure" qualifies for protection from liability.
(post is archived)